AISHA ODELL: Open Payments
NPI 1881066421 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 15 payments from 8 companies in 2025. Trend: 2023 $1,112 · 2024 $761 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $394 |
| Actelion Pharmaceuticals US, Inc. | 3 | $178 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: Barostim Neo System, UPTRAVI, VERQUVO, OPSUMIT, INSPIRE, JARDIANCE, BodyGuardian, FARXIGA.
Industry payments across TX — which companies pay providers there.
